Anna Kushnir

672 total citations
12 papers, 487 citations indexed

About

Anna Kushnir is a scholar working on Epidemiology, Molecular Biology and Virology. According to data from OpenAlex, Anna Kushnir has authored 12 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 4 papers in Molecular Biology and 4 papers in Virology. Recurrent topics in Anna Kushnir's work include Herpesvirus Infections and Treatments (5 papers), Poxvirus research and outbreaks (4 papers) and vaccines and immunoinformatics approaches (3 papers). Anna Kushnir is often cited by papers focused on Herpesvirus Infections and Treatments (5 papers), Poxvirus research and outbreaks (4 papers) and vaccines and immunoinformatics approaches (3 papers). Anna Kushnir collaborates with scholars based in United States, Poland and Canada. Anna Kushnir's co-authors include Judith M. White, Priscilla A. Schaffer, J. Robert Coleman, Sybil Tasker, David J. Davido, John W. Balliet, David A. Boltz, Charles B. Stauft, Steffen Mueller and Robert J. Baker and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Cell Biology and PLoS ONE.

In The Last Decade

Anna Kushnir

12 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Kushnir United States 10 237 194 168 108 56 12 487
Thomas Carsillo United States 11 196 0.8× 248 1.3× 223 1.3× 135 1.3× 73 1.3× 12 518
Bénédicte Machiels Belgium 13 204 0.9× 128 0.7× 83 0.5× 251 2.3× 51 0.9× 31 637
Masae Itoh Japan 16 438 1.8× 149 0.8× 300 1.8× 224 2.1× 98 1.8× 30 701
Fusako Ikeda Japan 12 419 1.8× 114 0.6× 301 1.8× 101 0.9× 77 1.4× 17 561
Vesna Brusic United States 10 112 0.5× 145 0.7× 240 1.4× 90 0.8× 65 1.2× 13 446
Adam Zuiani United States 8 102 0.4× 150 0.8× 203 1.2× 70 0.6× 36 0.6× 9 483
G. Florent Belgium 11 263 1.1× 229 1.2× 66 0.4× 185 1.7× 33 0.6× 25 619
Catherine A. Cotter United States 12 181 0.8× 149 0.8× 130 0.8× 80 0.7× 124 2.2× 18 439
J Peetermans Belgium 11 238 1.0× 67 0.3× 106 0.6× 57 0.5× 47 0.8× 29 364
Dengyun Sun United States 11 210 0.9× 87 0.4× 143 0.9× 118 1.1× 87 1.6× 14 377

Countries citing papers authored by Anna Kushnir

Since Specialization
Citations

This map shows the geographic impact of Anna Kushnir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Kushnir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Kushnir more than expected).

Fields of papers citing papers by Anna Kushnir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Kushnir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Kushnir. The network helps show where Anna Kushnir may publish in the future.

Co-authorship network of co-authors of Anna Kushnir

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Kushnir. A scholar is included among the top collaborators of Anna Kushnir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Kushnir. Anna Kushnir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Wang, Ying, Chen Yang, Yutong Song, et al.. (2021). Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy. Proceedings of the National Academy of Sciences. 118(29). 106 indexed citations
3.
Tasker, Sybil, et al.. (2021). 584. Phase 1 Placebo-Controlled Trial of COVI-VAC™, an Intranasal, Live Attenuated COVID-19 Vaccine. Open Forum Infectious Diseases. 8(Supplement_1). S394–S394. 1 indexed citations
4.
Mueller, Steffen, Charles B. Stauft, Raj Kalkeri, et al.. (2020). A codon-pair deoptimized live-attenuated vaccine against respiratory syncytial virus is immunogenic and efficacious in non-human primates. Vaccine. 38(14). 2943–2948. 40 indexed citations
5.
Stauft, Charles B., Chen Yang, J. Robert Coleman, et al.. (2019). Live-attenuated H1N1 influenza vaccine candidate displays potent efficacy in mice and ferrets. PLoS ONE. 14(10). e0223784–e0223784. 23 indexed citations
6.
Gelev, Vladimir, Janice M. Zabolotny, Martin Lange, et al.. (2014). A new paradigm for transcription factor TFIIB functionality. Scientific Reports. 4(1). 3664–3664. 15 indexed citations
7.
Mostafa, Heba H., Thornton W. Thompson, Anna Kushnir, et al.. (2011). Herpes Simplex Virus 1 ICP0 Phosphorylation Site Mutants Are Attenuated for Viral Replication and Impaired for Explant-Induced Reactivation. Journal of Virology. 85(23). 12631–12637. 17 indexed citations
8.
Kushnir, Anna, David J. Davido, & Priscilla A. Schaffer. (2009). Role of Nuclear Factor Y in Stress-Induced Activation of the Herpes Simplex Virus Type 1 ICP0 Promoter. Journal of Virology. 84(1). 188–200. 26 indexed citations
9.
Davido, David J., et al.. (2009). Transient Expression of Herpes Simplex Virus Type 1 ICP22 Represses Viral Promoter Activity and Complements the Replication of an ICP22 Null Virus. Journal of Virology. 83(17). 8733–8743. 19 indexed citations
10.
Balliet, John W., Anna Kushnir, & Priscilla A. Schaffer. (2007). Construction and characterization of a herpes simplex virus type I recombinant expressing green fluorescent protein: Acute phase replication and reactivation in mice. Virology. 361(2). 372–383. 26 indexed citations
11.
Balliet, John W., Anna Kushnir, Todd L. Astor, et al.. (2006). ICP22 Is Required for Wild-Type Composition and Infectivity of Herpes Simplex Virus Type 1 Virions. Journal of Virology. 80(19). 9381–9390. 35 indexed citations
12.
Kushnir, Anna, et al.. (2000). The Transmembrane Domain of Influenza Hemagglutinin Exhibits a Stringent Length Requirement to Support the Hemifusion to Fusion Transition. The Journal of Cell Biology. 151(2). 425–438. 176 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026